Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington’s Disease

por Rodrigues, Filipe Brogueira, Byrne, Lauren M., McColgan, Peter, Robertson, Nicola, Tabrizi, Sarah J., Zetterberg, Henrik, Wild, Edward J.
Publicado 2016

Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington’s disease

por Lowe, Alexander J., Sjödin, Simon, Rodrigues, Filipe B., Byrne, Lauren M., Blennow, Kaj, Tortelli, Rosanna, Zetterberg, Henrik, Wild, Edward J.
Publicado 2020

Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children

por Byrne, Lauren M., Schultz, Jordan L., Rodrigues, Filipe B., van der Plas, Ellen, Langbehn, Douglas, Nopoulos, Peggy C., Wild, Edward J.
Publicado 2022

Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease

por Byrne, Lauren M., Rodrigues, Filipe B., Johnson, Eileanoir B., De Vita, Enrico, Blennow, Kaj, Scahill, Rachael, Zetterberg, Henrik, Heslegrave, Amanda, Wild, Edward J.
Publicado 2018

Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI

por Rodrigues, Filipe B., Byrne, Lauren M., De Vita, Enrico, Johnson, Eileanoir B., Hobbs, Nicola Z., Thornton, John S., Scahill, Rachael I., Wild, Edward J.
Publicado 2019

Lumbar puncture safety and tolerability in premanifest and manifest Huntington’s disease: a multi-analysis cross-sectional study

por Hassan, Yara Refaat, Brogueira Rodrigues, Filipe, Zeun, Paul, Byrne, Lauren M., Estevez-Fraga, Carlos, Tortelli, Rosanna, Scahill, Rachael I., Wild, Edward J., Tabrizi, Sarah J.
Publicado 2022

Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay

por Fodale, Valentina, Boggio, Roberto, Daldin, Manuel, Cariulo, Cristina, Spiezia, Maria Carolina, Byrne, Lauren M., Leavitt, Blair R., Wild, Edward J., Macdonald, Douglas, Weiss, Andreas, Bresciani, Alberto
Publicado 2017

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease

por Rodrigues, Filipe B., Byrne, Lauren M., Lowe, Alexander J., Tortelli, Rosanna, Heins, Mariette, Flik, Gunnar, Johnson, Eileanoir B., De Vita, Enrico, Scahill, Rachael I., Giorgini, Flaviano, Wild, Edward J.
Publicado 2021

Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington’s disease

por Lowe, Alexander J, Rodrigues, Filipe B, Arridge, Marzena, De Vita, Enrico, Johnson, Eileanoir B, Scahill, Rachael I, Byrne, Lauren M, Tortelli, Rosanna, Heslegrave, Amanda, Zetterberg, Henrik, Wild, Edward J
Publicado 2022

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

por Byrne, Lauren M, Rodrigues, Filipe B, Blennow, Kaj, Durr, Alexandra, Leavitt, Blair R, Roos, Raymund A C, Scahill, Rachael I, Tabrizi, Sarah J, Zetterberg, Henrik, Langbehn, Douglas, Wild, Edward J
Publicado 2017

Neurofilament light protein in blood predicts regional atrophy in Huntington disease

por Johnson, Eileanoir B., Byrne, Lauren M., Gregory, Sarah, Rodrigues, Filipe B., Blennow, Kaj, Durr, Alexandra, Leavitt, Blair R., Roos, Raymund A., Zetterberg, Henrik, Tabrizi, Sarah J., Scahill, Rachael I., Wild, Edward J.
Publicado 2018

Characterizing White Matter in Huntington's Disease

por Gregory, Sarah, Johnson, Eileanoir, Byrne, Lauren M., Rodrigues, Filipe B., Henderson, Alexandra, Moss, John, Thomas, David, Zhang, Hui, De Vita, Enrico, Tabrizi, Sarah J., Rees, Geraint, Scahill, Rachael I., Wild, Edward J.
Publicado 2019

Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease

por Ou, Zhen-Yi Andy, Byrne, Lauren M., Rodrigues, Filipe B., Tortelli, Rosanna, Johnson, Eileanoir B., Foiani, Martha S., Arridge, Marzena, De Vita, Enrico, Scahill, Rachael I., Heslegrave, Amanda, Zetterberg, Henrik, Wild, Edward J.
Publicado 2021

A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study

por Lipsmeier, Florian, Simillion, Cedric, Bamdadian, Atieh, Tortelli, Rosanna, Byrne, Lauren M, Zhang, Yan-Ping, Wolf, Detlef, Smith, Anne V, Czech, Christian, Gossens, Christian, Weydt, Patrick, Schobel, Scott A, Rodrigues, Filipe B, Wild, Edward J, Lindemann, Michael
Publicado 2022

A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease

por Boeddrich, Annett, Haenig, Christian, Neuendorf, Nancy, Blanc, Eric, Ivanov, Andranik, Kirchner, Marieluise, Schleumann, Philipp, Bayraktaroğlu, Irem, Richter, Matthias, Molenda, Christine Mirjam, Sporbert, Anje, Zenkner, Martina, Schnoegl, Sigrid, Suenkel, Christin, Schneider, Luisa-Sophie, Rybak-Wolf, Agnieszka, Kochnowsky, Bianca, Byrne, Lauren M., Wild, Edward J., Nielsen, Jørgen E., Dittmar, Gunnar, Peters, Oliver, Beule, Dieter, Wanker, Erich E.
Publicado 2023

Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis

por Scahill, Rachael I, Zeun, Paul, Osborne-Crowley, Katherine, Johnson, Eileanoir B, Gregory, Sarah, Parker, Christopher, Lowe, Jessica, Nair, Akshay, O'Callaghan, Claire, Langley, Christelle, Papoutsi, Marina, McColgan, Peter, Estevez-Fraga, Carlos, Fayer, Kate, Wellington, Henny, Rodrigues, Filipe B, Byrne, Lauren M, Heselgrave, Amanda, Hyare, Harpreet, Sampaio, Cristina, Zetterberg, Henrik, Zhang, Hui, Wild, Edward J, Rees, Geraint, Robbins, Trevor W, Sahakian, Barbara J, Langbehn, Douglas, Tabrizi, Sarah J
Publicado 2020